Plant science company Syngenta has submitted a legal challenge to the European Commission’s decision to suspend the use of the neonicotinoid thiamethoxam on bee-attractive crops.
According to Syngenta, the EC 'took the decision on the basis of a flawed process, an inaccurate and incomplete assessment by the European Food Safety Authority and without the full support of EU Member States'.
“We would prefer not to take legal action but have no other choice given our firm belief that the Commission wrongly linked thiamethoxam to the decline in bee health,' said Syngenta COO John Atkin. 'In suspending the product, it breached EU pesticide legislation and incorrectly applied the precautionary principle.
“Since the EU suspension of thiamethoxam was announced, farmers and farmer organisations have expressed great concern that an extremely effective, low dose product will not be available to them and will have to be replaced by much less sustainable alternatives,' Atkin outlined. 'Modern products like thiamethoxam are essential to address the challenge of increasing European food production and reducing the reliance on imports.”
Syngenta called on stakeholders to concentrate on practical solutions to bee health, which it said most experts agree is 'damaged by disease, viruses and the loss of habitat and nutrition.'
The company also confirmed its commitment to support the expansion of Operation Pollinator across Europe and the Bee Health Action Plan, which was first published in April 2013.
